Skip to content
PubMed This is a summary of 7 peer-reviewed journal articles Updated
Dermatology

What Is a Salt-Split Skin Test for Bullous Pemphigoid?

At a Glance

Salt-split testing shows where antibodies bind in a skin sample. Roof binding supports bullous pemphigoid, while floor binding suggests other blistering diseases. Doctors interpret the pattern with symptoms and other tests because a negative result does not rule out bullous pemphigoid.

The salt-split skin test is a specialized laboratory technique used to help diagnose and distinguish different types of autoimmune blistering diseases, such as bullous pemphigoid (BP). When you have a blistering condition, your immune system mistakenly creates antibodies that attack the proteins holding your skin layers together. In a salt-split skin test, a skin sample is bathed in a special concentrated salt solution in the laboratory. This artificially separates the top layer of skin (the epidermis) from the bottom layer (the dermis) at the basement membrane zone—the thin anchoring region between these two layers [1]. This split allows the pathologist to see where your antibodies are attaching: either to the “roof” (epidermal side) or the “floor” (dermal side) of the artificial blister [1][2].

Note: The salt solution is only used on tissue samples in the laboratory, never on your actual body.

Why is it Done?

A standard skin biopsy (routine histology) can show what a blister looks like under a microscope, but it cannot prove the cause is autoimmune. To get a complete diagnosis, dermatologists look at your clinical symptoms alongside specific tests like direct immunofluorescence (which looks for immune deposits in your skin) and blood tests (which look for specific antibodies like BP180 or BP230).

However, several autoimmune blistering diseases can look very similar even on these specialized tests. The salt-split skin test provides an extra localization clue. By splitting the skin layers apart, doctors can observe the specific pattern of antibody binding:

  • Roof-binding (Epidermal side): If the antibodies stick to the top layer of the separated skin, it strongly supports a diagnosis of bullous pemphigoid, though it can sometimes be seen in other related conditions [1][3].
  • Floor-binding (Dermal side): If the antibodies stick to the bottom layer, it suggests a different, less common condition, such as epidermolysis bullosa acquisita (EBA), anti-p200 pemphigoid, or anti-laminin 332 pemphigoid [3][4]. These are rare blistering diseases that target different proteins deeper in the basement membrane zone.

Knowing exactly which proteins are being targeted helps your doctor confirm your specific diagnosis, which can help guide your treatment plan.

How the Test is Performed

There are two main ways the salt-split technique can be used in the lab:

  • Indirect Immunofluorescence (Blood Test): This is the most common method. The lab takes normal, healthy donor skin and bathes it in a salt solution to split the layers. Then, they apply a sample of your blood serum to this artificially split skin. A fluorescent dye is used to see if the antibodies in your blood attach to the “roof” or the “floor” [1][2]. For you, this just requires a standard blood draw.
  • Direct Immunofluorescence (Biopsy): In specialized cases, the lab might perform the salt-split technique directly on a piece of skin taken from your biopsy. They split your biopsied skin in the salt solution to see where the antibodies have already deposited themselves [1]. For you, this involves a skin biopsy taken from an area next to a blister.

Understanding Your Results

If your pathology report mentions a salt-split skin test, it will typically describe the pattern of fluorescence (glowing dye) as either on the epidermal side (roof) or dermal side (floor).

  • Epidermal roof staining: This is the classic result that is consistent with bullous pemphigoid [1][3]. It supports the diagnosis by showing the target of your immune system’s attack is located on the upper side of the skin’s basement membrane.
  • Dermal floor staining: This means the antibodies are targeting proteins slightly deeper in the basement membrane zone. While it raises the possibility of epidermolysis bullosa acquisita (EBA), it can also be seen in anti-p200 or anti-laminin 332 pemphigoid [3][4]. Floor-binding results often prompt your doctor to order additional, more specific tests to pinpoint the exact disease [5][6].
  • Mixed patterns or negative results: Sometimes, antibodies bind to both the roof and the floor [4][7]. Other times, the test might be negative despite other signs of the disease, which can happen if antibody levels in the sample are too low to detect [5]. A negative result does not rule out bullous pemphigoid.

What This Test Can and Cannot Tell You

  • It Can: Help localize where your antibodies are attacking, which provides a strong clue about the specific type of blistering disease you have.
  • It Cannot: Measure the severity of your disease, determine your prognosis, or diagnose you all by itself. Your doctor will interpret this single test alongside your symptoms, other biopsies, and specific blood tests.

Reading unfamiliar pathology language can be stressful. You do not need to interpret this report alone—your dermatologist will explain what your specific results mean in the context of your overall health.

Common questions in this guide

What does a salt-split skin test look for in bullous pemphigoid?
It separates the epidermis, or top skin layer, from the dermis, or deeper layer, in a laboratory sample and checks where antibodies attach. The pattern gives doctors a clue about whether bullous pemphigoid or another autoimmune blistering disease is more likely, but it is not used alone to make a diagnosis.
What does roof staining mean on a salt-split test?
Roof, or epidermal-side, staining is the classic pattern associated with bullous pemphigoid. It supports the diagnosis but can also occur in some related conditions, so doctors compare it with symptoms and other biopsy or blood-test results.
What does floor staining mean on a salt-split test?
Floor, or dermal-side, staining means antibodies are binding to a deeper part of the skin’s anchoring zone. It can suggest epidermolysis bullosa acquisita, anti-p200 pemphigoid, or anti-laminin 332 pemphigoid, and usually leads to additional testing to identify the specific condition.
Is the salt-split skin test done with blood or a biopsy?
The most common version is an indirect test that uses a blood sample applied to specially treated donor skin in the laboratory. A direct version uses a skin biopsy, so your dermatologist can tell you which method was used and how to interpret it.
Can a negative salt-split skin test rule out bullous pemphigoid?
No. A negative result can occur when antibody levels are too low to detect, so it does not rule out bullous pemphigoid. Doctors interpret it alongside symptoms, biopsy findings, and blood tests for antibodies such as BP180 or BP230.
Does the test show how severe bullous pemphigoid is?
No. The salt-split skin test helps locate where antibodies bind and may help distinguish blistering diseases, but it does not measure disease severity or predict the outcome. Your dermatologist uses the full clinical picture to plan care.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Did my salt-split skin test show roof-binding or floor-binding?
  2. 2.How do these test results align with my clinical symptoms and my other biopsy findings?
  3. 3.Were BP180 or BP230 antibodies tested, and what is the complete diagnosis based on all results?
  4. 4.Given my salt-split results, do we need to run any additional tests to confirm the specific type of blistering disease I have?
  5. 5.How does this specific diagnosis affect my overall treatment plan and follow-up?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (7)
  1. 1

    Assessment of Diagnostic Strategy for Early Recognition of Bullous and Nonbullous Variants of Pemphigoid.

    Meijer JM, Diercks GFH, de Lang EWG, et al.

    JAMA dermatology 2019; (155(2)):158-165 doi:10.1001/jamadermatol.2018.4390.

    PMID: 30624575
  2. 2

    Distinguishing Epidermolysis Bullosa Acquisita From Bullous Pemphigoid Without Direct Immunofluorescence.

    Gardner KM, Crawford RI

    Journal of cutaneous medicine and surgery 2018; (22(1)):22-24 doi:10.1177/1203475417722734.

    PMID: 28719980
  3. 3

    Anti-P 200 pemphigoid - The most common floor binding subepidermal autoimmune bullous disease in a tertiary care center in south India.

    Rai R, Anand JB, Shanmugasekar C, et al.

    Indian journal of dermatology, venereology and leprology 2021; (87(6)):787-791.

    PMID: 34160166
  4. 4

    Epidermolysis bullosa acquisita and anti-p200 pemphigoid as major subepidermal autoimmune bullous diseases diagnosed by floor binding on indirect immunofluorescence microscopy using human salt-split skin.

    Goyal N, Rao R, Shenoi SD, et al.

    Indian journal of dermatology, venereology and leprology 2017; (83(5)):550-555 doi:10.4103/ijdvl.IJDVL_678_16.

    PMID: 28749386
  5. 5

    Serration pattern analysis as a practical adjunct tool for categorization of subepidermal autoimmune blistering diseases.

    Arora S, Shetty VM, Rao CR, et al.

    Indian journal of dermatology, venereology and leprology 2021; (87(6)):778-786.

    PMID: 34491679
  6. 6

    Laboratory Diagnosis and Clinical Profile of Anti-p200 Pemphigoid.

    Meijer JM, Diercks GF, Schmidt E, et al.

    JAMA dermatology 2016; (152(8)):897-904 doi:10.1001/jamadermatol.2016.1099.

    PMID: 27167149
  7. 7

    Case of epidermolysis bullosa acquisita with concomitant anti-laminin-332 antibodies.

    Nishida E, Nishio E, Murashima H, et al.

    The Journal of dermatology 2018; (45(4)):472-474 doi:10.1111/1346-8138.14169.

    PMID: 29205468

This page is for informational purposes only and does not replace medical advice about a salt-split skin test or bullous pemphigoid. Ask your dermatologist to interpret your result alongside your symptoms and other tests.

Get notified when new evidence is published on Bullous pemphigoid.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.